poisar

Stock

Rani Therapeutics Holdings, Inc. RANI

$0.85+1.03%

Overview

RANI market data

Price History

RANI price chart · 1M
O
0.857400
H
0.859900
L
0.853600
C
0.853600
Vol
2,685.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$0.86
Previous Close
$0.84
Day High
$0.86
Day Low
$0.85
52 Week High
$1.14
52 Week Low
$0.61
7 Day Return
-1.36%
30 Day Return
+3.71%
90 Day Return
-10.26%
1 Year Return
-1.39%
Daily Notional Volume
$2.3K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.45
Diluted earnings per share over the trailing twelve months.
Beta
0.78
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-547.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.44 – $3.87
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $108.8M · P/B 4.97 · P/S 34.33.

Company News

8 captured
HC Wainwright & Co. Reiterates Buy on Rani Therapeutics Hldgs, Maintains $11 Price TargetBenzinga · Aug 21, 2026, 10:31 AM
This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · Aug 18, 2026, 12:45 PM
Chardan Capital Initiates Coverage On Rani Therapeutics Hldgs with Buy Rating, Announces Price Target of $6Benzinga · Aug 18, 2026, 11:53 AM
Rani Therapeutics Hldgs Q2 EPS $(0.04) Beats $(0.05) Estimate, Sales $1.708M Beat $925.000K EstimateBenzinga · Aug 13, 2026, 8:32 PM
8-K filing — Rani Therapeutics Holdings, Inc. (RANI)SEC EDGAR · Aug 13, 2026, 8:11 PM
Rani Therapeutics Reports Initial Phase 1 Data Showing Oral RT‑114 Delivered Systemic Exposure Exceeding Matched Subcutaneous Administration, With Safety And Tolerability Consistent With GLP‑1/GLP‑2 Agonist ClassBenzinga · Jul 15, 2026, 12:04 PM
Rani Therapeutics Partners With PegBio To Mull Delivery Of Multiple Novel Candidates From PegBio's Obesity And Metabolic Disease Pipeline Through RaniPill PlatformBenzinga · Jul 9, 2026, 8:10 PM
Rani Therapeutics Appoints Nicholas Maestas As CFO; Succeeds Svai SanfordBenzinga · Jun 29, 2026, 12:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock